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Ectopia lentis is a genetically heterogeneous condition that is characterized by the subluxation of the lens resulting from the disruption
of the zonular ﬁbers. Patients with ectopia lentis commonly present with a marked loss in visual acuity in addition to a number of
possibly accompanying ocular complications including cataract, myopia, and retinal detachment. We here describe an isolated form
of ectopia lentis in a large inbred family that shows autosomal-recessive inheritance. We map the ectopia lentis locus in this family
to the pericentromeric region on chromosome 1 (1p13.2-q21.1). The linkage region contains well more than 60 genes. Mutation
screening of four candidate genes revealed a homozygous nonsense mutation in exon 11 of ADAMTSL4 (p.Y595X; c.1785T/G) in
all affected individuals that is absent in 380 control chromosomes. The mutation would result in a truncated protein of half the original
length, if the mRNA escapes nonsense-mediated decay. We conclude that mutations in ADAMTSL4 are responsible for autosomal-reces-
sive simple ectopia lentis and that ADAMTS-like4 plays a role in the development and/or integrity of the zonular ﬁbers.Ectopia lentis (EL) is a rare condition characterized by
partial or complete displacement of the lens from its space.
In the absence of traumatic injury, the occurrence of EL is
predominantly attributed to hereditary systemic diseases,
such asMarfan syndrome (MFS [MIM 154700]),1 homocys-
tinuria (CBS [MIM 236200]),2 and Weill-Marchesani
syndrome (WMS [MIM 277600; 608328]);3 however, EL
can present as an isolated condition.4–6 Despite its clinical
homogeneity, isolated EL is genetically heterogeneous
with both autosomal-dominant (MIM 129600)5 and -reces-
sive (MIM 225100) forms.7,8
Patients with EL commonly present with marked loss in
visual acuity that varies with the degree of lens subluxa-
tion.9 Accompanying complications include myopia,10
retinal detachment,10 cataract,11 and glaucoma.12
Although the disruption of the zonular ﬁbers supporting
the lens has been established as the underlying pathology
of EL,13 no comprehensive theory of the pathogenesis has
emerged. The zonular ﬁbers are microﬁbrillar structures
that are not associated with elastin, but share common
antigenic determinants with the elastin-associatedmicroﬁ-
brils.14 Mutations in FBN1 (MIM 134797) encoding ﬁb-
rillin have been reported to cause Marfan syndrome15
and were described in association with the autosomal-
dominant form of Weill-Marchesani syndrome,3 both
syndromes associated with EL.
To identify the gene responsible for an autosomal-reces-
sive isolated EL, we recruited members of a previously
described inbred family from Jordan with 15 affected indi-
viduals, from 4 related sibships.8 The diagnosis was based
on ocular involvement without systemic manifestations.
In all examined affected individuals, the corneas were
clear, pupils were round and normal, and there were no274 The American Journal of Human Genetics 84, 274–278, Februarareas of iris atrophy or positive iris transillumination.
The displacement of the lens was variable among the
examined affected individuals. Complications found in
the affected family members include deprivation ambly-
opia, retinal detachment, and cataract. A recent clinical
review of all affected family members showed a stable
ocular condition, without any major changes. A detailed
family history was obtained and a three-generation pedi-
gree was constructed (Figure 1A). The participants in this
study are from two related sibships with ﬁrst cousin
parents: four affected individuals and six of their unaf-
fected relatives. Informed consent was obtained from all
participating family members or their legal guardians,
and the informed consent document was approved by
the local IRB of Jordan University of Science and Tech-
nology, Irbid, Jordan. We also obtained 190 unrelated,
ethnically matched anonymous DNA samples, which
were used as controls.
DNAwas extracted fromwhole blood via standard proce-
dures. A genome-wide scan for linkage was performed with
the ABI PRISM linkage mapping set of ﬂuorescent microsa-
tellite DNA markers, version 2 (PE Biosystems, Foster City,
CA). The regions of homozygosity were inspected and one
region around the centromere of chromosome 1 was the
most signiﬁcant. To reﬁne the region, all family members
were genotyped with additional nonﬂuorescent microsa-
tellite markers. The ampliﬁed products of the polymerase
chain reaction (PCR) were analyzed on 6% acrylamide
gel; 5 M urea and the bands detected by silver staining.16
The genome-wide linkage screen identiﬁed the pericentro-
meric region on chromosome 1 (1p13.2-q21.1) as the
region of linkage and ﬁne mapping identiﬁed a 35 Mb
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of which about 20 Mb are heterochromatic in nature
(centromere and 1q12) and do not contain genes.
Two-point and multipoint LOD score analysis was per-
formed with MLINK of the FASTLINK computer program
package17 and ALLEGRO,18,19 respectively. The genetic
and physical map distances for the genome scan and the
ﬁne mapping markers were obtained from the Rutgers
combined linkage-physical map (Build 35).20 The analysis
was conducted assuming an autosomal-recessive mode of
inheritance with full penetrance and no phenocopies. A
disease allele frequency of 0.001 was used in the analysis.
The allele frequency for all markers was assumed to be
equal, because the true allele frequency for the population
is unknown. A LOD score of 3 or higher was used to estab-
lish linkage. A maximum two-point LOD score of 3.3 was
obtained for marker D1S534 at (q) ¼ 0 (Table 1) and
a maximum multipoint LOD score of 4.4 occurred at
markers D1S250, D1S467, and D1S189 (results not
shown). Both the region of homozygosity and the 3-unit
Figure 1. The Family Pedigree, Haplo-
type, and ADAMTSL4 Mutation
(A) Reduced pedigree of the family
showing only participating members and
their immediate relatives. The genotypes
of eight microsatellite markers are shown
with the arrows pointing to the crossover
events that delineate the region of linkage.
(B) Sequence chromatograph showing the
T/G transversion producing a premature
stop codon TAG.
Table 1. Two-Point LOD Scores between EL and Chromosome
1p13.2-1q21.1 Polymorphic Markers
LOD Score at Recombination Fractions (q)
Marker
Marker
Position q0 q0.01 q0.02 q0.05 q0.1 q0.2 q0.3
D1S1675 114.5 - N 1.14 1.37 1.56 1.51 1.13 0.69
D1S250 115.0 3.21 3.13 3.05 2.82 2.43 1.65 0.93
D1S467 115.8 2.91 2.84 2.77 2.56 2.21 1.50 0.82
D1S189 116.5 2.56 2.50 2.43 2.24 1.91 1.26 0.65
D1S2744 117.1 3.21 3.14 3.06 2.84 2.46 1.71 0.98
D1S534 119.5 3.30 3.18 3.11 2.88 2.50 1.72 0.98
D1S3466 148.5 3.05 2.98 2.90 2.69 2.33 1.60 0.91
D1S498 149.6 0.40 0.99 1.22 1.42 1.40 1.05 0.59
support interval are delineated by
markers D1S1675 and D1S498.
The critical region comprises more
than 60 known and predicted genes.
In silico investigation of genes in
the critical region of linkage was
performed to generate a priority list
for sequencing. Four genes ANXA9
(MIM 603319), MAN1A2 (MIM
604345), ADAM30 (MIM 604779),
and ADAMTSL4 (MIM 610113) were
short listed and their genomic
sequences were obtained from the
public databases. Primers were de-
signed to amplify all exons, splice
sites, and the ﬂanking sequences
(Table S1 available online). Sequen-
cing of the ampliﬁed fragments was
initially performed for an obli-
gate carrier, an affected individual
from the same family, and a normal
unrelated control. The allele fre-
quency of identiﬁed variations was
determined by genotyping 190 ethni-
cally matched controls. Sequence analysis of the selected
candidate genes revealed a nonsense mutation in exon
11:c.1785T/G (p.Y595X) of ADAMTSL4, which changes
an evolutionary conserved tyrosine to a prematureThe American Journal of Human Genetics 84, 274–278, February 13, 2009 275
termination codon, resulting in a truncated protein of 594
amino acids, if a protein is made (Figure 1B). This mutation
segregates with the phenotype in the examined family
members and was not found in 380 ethnically matched
control chromosomes.
To determine the expression pattern of ADAMTSL4, ﬁrst-
strand cDNA libraries from an adult and fetal multiple-
tissue human panel were obtained commercially
(Genemed Biotechnologies, Inc; South San Francisco,
CA). We designed primers to amplify two fragments,
340 bp and 481 bp, from the full-length cDNA of
ADAMTSL1 (Table S2). The 340 bp fragment detects the
two major reported isoforms (a and b) whereas the 481 bp
fragment detects only isoform a (full length). A 900 bp
b-actin fragment was used as a positive control for gene
expression. Ampliﬁcation of ﬁrst-strand cDNA from adult
human tissue showed expression of ADAMTSL4 in colon,
heart, leukocyte, liver, lung, skeletal muscle, spleen, testis,
and placenta; expression was weaker in bone marrow,
brain tissue, kidney, and pancreas (Figure 2). On the other
hand, the expression study in fetal tissue revealed strong
expression in heart, kidney, liver, lung, and skeletal
muscle, but weaker expression in brain and skin (Figure 3).
Expression of ADAMTSL4 has been shown to occur in
human and mouse eye tissue.21
The genomic structure of ADAMTSL4 was obtained from
the public databases. The genomic sequence of ADAMTSL4
consists of 19 exons spanning about 11.5 kb on chromo-
some 1q21.2. The full-length mRNA is 4209 bp and
encodes a 1074 amino acid protein (116.5 kDa), which
displays a 76% homology with the mouse Adamtsl4
protein.21 Alternative transcriptional splice variants en-
Figure 2. Expression of ADAMTSL4 in
cDNA
The top panel shows expression in the
cDNA libraries from adult human tissues,
whereas the bottom panel shows expres-
sion in fetal tissues. The 340 bp fragment
detects the two major reported isoforms
(a and b) whereas the 481bp fragment
detects only isoform a (full length).
coding different isoforms have been
characterized, with two major iso-
forms, a (full length) and b. The
mRNA of second isoform, b, encodes
an 877 amino acid protein that lacks
the last 200 amino acids (Figure 3).
The 50 untranslated region is 236 bp
long and the translation initiation
codon is in exon 3. The 30 untrans-
lated region is 740 bp long and follows
of the termination codon in exon 19.
The ADAMTS-like 4 comprises seven
thrombospondin type 1 repeats
(TSP1), one ADAM-TS Spacer 1 domain (that contains the
reported mutation), a PLAC domain, and a leucine zipper
domain (Figure 3). The protein is predicted to localize in
the extracellular matrix. The investigation of an inbred
Arabic family with autosomal-recessive isolated EL has
revealed an inherently damaging p.Y595X nonsensemuta-
tion. The mutation would result in a truncated protein of
594 amino acids that lacks 6 of the 7 thrombospondin
type 1 repeats, if it escapes nonsense-mediated mRNA
decay. The mutation affects both major isoforms.
ADAMTSL4 belongs to a large superfamily containing
19 ADAMTS proteases22 and at least ﬁve ADAMTS-like
proteins. They are believed to be anchored to the extracel-
lularmatrix (ECM) through interactionwithmatrix compo-
nents via one or more TSP1 domains. The ADAMTS super-
family is involved in various biological processes including
connective tissue organization, coagulation, inﬂammation,
arthritis, angiogenesis, and cell migration.22 Mutations in
ADAMTS10 (MIM 608990) have been implicated in the
autosomal-recessiveWeill-Marchesani syndrome, a connec-
tive-tissue disorder that includes EL in its phenotype.23
Mutations in FBN1 are responsible for the autosomal-domi-
nantWeill-Marchesani syndrome.24 This suggests a role for
ADAMTS10 in ECM and connective-tissue remodeling, and
also suggests a signiﬁcant interactionwithﬁbrillin1, amajor
component of the zonular ﬁbers.
The ADAMTS-like subfamily comprises proteins homol-
ogous to the ADAMTS ancillary domains but are lacking
the protease domain and hence lack catalytic activity.
Mutations in ADAMTSL2 are responsible for the auto-
somal-recessive geleophysic dysplasia probably through
the dysregulation of TGF-b signaling.25 The identiﬁcation276 The American Journal of Human Genetics 84, 274–278, February 13, 2009
Figure 3. Diagram of ADAMTSL4 and Its Isoforms
Diagramatic presentation of ADAMTSL4, ADAMTSL4 and its two isoforms a (full length) and b. The protein domains are shown, as well as
the position of the identified mutation that is present in the two major isoforms. Isoform b lacks three TSP1 domains and the PLAC
domain.of the interaction of ADAMTSL4 and ECM proteins,
including ﬁbrillin, may shed some light on the pathoge-
netic mechanism relevant to EL. It has been suggested
that defective connective tissue remodeling is the pathoge-
netic mechanisms behind autosomal-recessive Weill-Mar-
chesani syndrome, a function that is performed by
ADAMTS10 catalytic activity.23 ADAMTSL4 lacks this or
similar catalytic activities, so the hypothesis would be
that it plays a structural role in the assembly or integrity
of ECM or both. Alternatively, its role may be in a signaling
pathway similar to ADAMTSL2.25
The presence of only ocular manifestations in this family
without systemic manifestations should not exclude an
integral role of ADAMTSL4 in all microﬁbrillar ﬁbers
throughout the body. It would be hypothesized that the
absence of ADAMTSL4 function is only apparent in the
zonular ﬁbers because these ﬁbers experience slow turn-
over26 and as such, a temporal onset weakness in their
structure is not seen elsewhere because of rapid turnover
in other tissues. Alternatively, other ADAMTS-like
proteins, or any other proteins for that matter, may
compensate for the absence of ADAMTSL4 protein in non-
ocular tissue in affected individuals.
Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.ajhg.org/.
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